Kigali, Nairobi & San Francisco, CA
March 15, 2024
BIO USAWA INC. is pleased to announce its participation in the prestigious African Diaspora Network Forum, scheduled to occur from March 20th to 22nd 2024 at the Hayes Mansion in San Jose, California, USA.
Bio Usawa is excited to participate in this esteemed event, which brings together Africans, diasporans, and friends of Africa. Dr. Menghis Baairu, co-founder, President and CEO of Bio Usawa and Dr. Richard Chin, co-founder Chairman will represent the company at the forum.
Bio Usawa is in the process of implementing its plan to establish a facility in Africa to manufacture lifesaving, quality, affordable monoclonal antibodies for Cancer, Autoimmune and Ophthalmological Diseases.
Indeed, a staggering 80% of the pre-seed investors in Bio Usawa hail from the African Diaspora. This impressive figure not only highlights the global reach of Bio Usawa, but also underscores the unwavering dedication and passion of the global African community to the continent's development.
If you are attending and interested in learning more about our mission and explore opportunities for collaboration, please reach out to us via email at [email protected].
We are looking forward to fostering meaningful dialogues, forging lasting connections, and contributing to the collective vision of a prosperous and sustainable Africa at the African Diaspora Network Forum Symposium.
ABOUT BIO USAWA INC
Our mission is to make Affordable, Essential, High Quality Biologic Medicines for Africans, made by Africans in Africa
Bio Usawa will be participating in the 6th Annual African Retina Society (ARS 2026) Conference, taking place on 12–13 June 2026 in Addis Ababa, Ethiopia…
June 2026At the Africa CEO Forum in Kigali last week, Bio Usawa CEO Dr. Menghis Bairu attended a presidential panel that tackled a question central to Africa’s e…
May 2026At the Rwanda Global Gateway Investment Roadshow this week, our CEO & President Dr. Menghis Bairu joined leaders from government, development finance in…
May 2026